PI3 Kinase p110 beta Polyclonal Antibody

Cat.#: 160199

Special Price 174.2 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    PI3 Kinase p110 beta Polyclonal Antibody
  • Documents
  • Description
    Polyclonal antibody to PI3 Kinase p110 beta
  • Tested applications
    WB, IHC, IF
  • Species reactivity
    Human, Mouse, Rat
  • Alternative names
    PIK3CB antibody; P110BETA antibody; PI3K antibody; PI3KBETA antibody; PIK3C1 antibody; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta antibody
  • Isotype
    Rabbit IgG
  • Preparation
    Antigen: Recombinant fusion protein containing a sequence corresponding to amino acids 771-1070 of human PI3 Kinase p110 beta (NP_006210.1).
  • Clonality
    Polyclonal
  • Formulation
    PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
  • Storage instructions
    Store at -20℃. Avoid freeze / thaw cycles.
  • Applications
    WB 1:500 - 1:2000
    IHC 1:50 - 1:100
    IF 1:50 - 1:100
  • Validations

    Western blot - PI3 Kinase p110 beta Polyclonal Antibody

    Western blot - PI3 Kinase p110 beta Polyclonal Antibody

    Western blot analysis of extracts of various cell lines, using PI3 Kinase p110 beta antibody at 1:1000 dilution.Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution.Lysates/proteins: 25ug per lane.Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Enhanced Kit .Exposure time: 90s.

    Immunohistochemistry - PI3 Kinase p110 beta Polyclonal Antibody

    Immunohistochemistry - PI3 Kinase p110 beta Polyclonal Antibody

    Immunohistochemistry of paraffin-embedded mouse lung using PI3 Kinase p110 beta antibody at dilution of 1:100 (40x lens).

    Immunohistochemistry - PI3 Kinase p110 beta Polyclonal Antibody

    Immunohistochemistry - PI3 Kinase p110 beta Polyclonal Antibody

    Immunohistochemistry of paraffin-embedded human lung using PI3 Kinase p110 beta antibody at dilution of 1:100 (40x lens).

    Immunohistochemistry - PI3 Kinase p110 beta Polyclonal Antibody

    Immunohistochemistry - PI3 Kinase p110 beta Polyclonal Antibody

    Immunohistochemistry of paraffin-embedded human colon carcinoma using PI3 Kinase p110 beta antibody at dilution of 1:100 (40x lens).

  • Background
    Phosphoinositide-3-kinase (PI3K) that phosphorylates PtdIns (Phosphatidylinositol), PtdIns4P (Phosphatidylinositol 4-phosphate) and PtdIns(4,5)P2 (Phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Involved in the activation of AKT1 upon stimulation by G-protein coupled receptors (GPCRs) ligands such as CXCL12, sphingosine 1-phosphate, and lysophosphatidic acid. May also act downstream receptor tyrosine kinases. Required in different signaling pathways for stable platelet adhesion and aggregation. Plays a role in platelet activation signaling triggered by GPCRs, alpha-IIb/beta-3 integrins (ITGA2B/ ITGB3) and ITAM (immunoreceptor tyrosine-based activation motif)-bearing receptors such as GP6. Regulates the strength of adhesion of ITGA2B/ ITGB3 activated receptors necessary for the cellular transmission of contractile forces. Required for platelet aggregation induced by F2 (thrombin) and thromboxane A2 (TXA2). Has a role in cell survival. May have a role in cell migration. Involved in the early stage of autophagosome formation. Modulates the intracellular level of PtdIns3P (Phosphatidylinositol 3-phosphate) and activates PIK3C3 kinase activity. May act as a scaffold, independently of its lipid kinase activity to positively regulate autophagy. May have a role in insulin signaling as scaffolding protein in which the lipid kinase activity is not required. May have a kinase-independent function in regulating cell proliferation and in clathrin-mediated endocytosis. Mediator of oncogenic signal in cell lines lacking PTEN. The lipid kinase activity is necessary for its role in oncogenic transformation. Required for the growth of ERBB2 and RAS driven tumors.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"